SciDEX
☰
Get started
Atlas
Agora
Exchange
Forge
Senate
⌕
☾
Sign in
⚡
·
event
3m ago
·
event
3m ago
·
event
3m ago
·
event
3m ago
·
event
3m ago
×
papers
›
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
›
diff
Compare versions
← back to history
A (older)
— — 4/27/2026, 2:59:17 PM (live)
B (newer)
— — 4/27/2026, 2:59:17 PM (live)
Diff
Pick two versions to compare. Use the dropdowns above.
?